摘要
缺血性脑卒中、慢性心房颤动和心脏瓣膜术后的患者经常需要长期口服抗凝药物治疗,以降低血栓或栓塞性脑血管疾病的发生。而抗凝药物的长期服用容易引发脑出血(in-tracerebral hemorrhage,ICH)。这类由抗凝药物引发的ICH(anticoagulant therapy associated ICH,ACT-ICH)预后差,病死率高,且无公认的治疗方案。
出处
《中国医师进修杂志(内科版)》
2008年第4期77-78,共2页
Chinese Journal of Postgraduates of Medicine
参考文献3
-
1范蓉,尹琳,王乃昌,包礼平.缺血性脑卒中患者脑出血风险预测因素[J].华北煤炭医学院学报,2007,9(2):149-150. 被引量:2
-
2Joseph Broderick,Sander Connolly,Edward Feldmann,Daniel Hanley,Carlos Kase,Derk Krieger,Marc Mayberg,Lewis Morgenstern,Christopher S. Ogilvy,Paul Vespa,Mario Zuccarello,王玉洁(译),刘娟(译),白璇(译),李新辉,孙虹(译),姚志成(译),张慧(译),牛英翔(译).成人自发性脑出血处理指南——2007年更新版:美国心脏协会/美国卒中协会卒中委员会、高血压研究委员会、医疗质量和转归研究跨学科工作组指南:美国神经病学学会确认本指南作为神经科医生教学工具的价值[J].国际脑血管病杂志,2007,15(7):484-504. 被引量:236
-
3李永杰,高旭光.重视抗栓治疗相关性脑出血[J].中国卒中杂志,2006,1(2):120-123. 被引量:8
二级参考文献237
-
1[1]Petty Gw.Frenqency of major complications of aspirin,warfarin,and introvennous heparin for secondary stroke prevention[J].Ann Intem Med,1999,256(1):14
-
2[2]PROGRESS Collaborative Group.Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischemic attack[J].Lancet,2001,358:1033
-
3[3]Chapman N,Huxley R,Anderson C,et al.Effects of a peindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke sub type and medical history[J].The Progress Trial Stroke,2004,35:116
-
4[4]Perry H,Davis B,Price T,et al.Effects of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke[J].JAMA,2000,284:465
-
5[5]Anand SS.Yusuf S.Oral andticoagulant therapy in patients with coronas artery disease:A meta-analtsis[J].JAMA,1999,282(4):2058
-
6[1]Walters MR,Muir KW,Harbison J,et al.Intravenous thrombolysis for acute ischaemic stroke:preliminary experience with recombinant tissue plasminogen activator in the UK[J].Cerebrovasc Dis,2005,20(6):438 -442.
-
7[2]Cocho D,Borrell M,Marti-Fabregas J,et al.Pretreatment Hemostatic Markers of Symptomatic Intracerebral Hemorrhage in Patients Treated With Tissue Plasminogen Activator[J].Stroke,2006,37:996-999.
-
8[3]Flaherty ML,Woo D,Kissela B,et al.Combined Ⅳ and intra-arterial thrombolysis for acute ischemic stroke[J].Neurology,2005,64(2):386 -388.
-
9[4]Ruiz-Bailen M,Brea-Salvago JF,De Hoyos EA,et al.Post -thrombolysis intracerebral hemorrhage:data from the Spanish Register ARIAM[J].Crit Care Med,2005,33 (8):1829 -1838.
-
10[5]McCarron MO,Nicoll JA.Cerebral amyloid angiopathy and thrombolysis-related intracerebral haemorrhage[J].Lancet Neurol,2004,3(8):484-492.
共引文献241
-
1张鹏,李育平,汤灿(综述),张恒柱(审校).慢性硬膜下血肿与凝血相关因素的研究进展[J].中国微侵袭神经外科杂志,2020,0(1):43-45. 被引量:9
-
2国家神经疾病医学中心,中国医师协会神经介入专业委员会,世界华人神经外科医师协会放射神经外科专家委员会,洪韬,朱巍,孙时斌,陈光忠,于嘉兴.脑动静脉畸形多学科诊疗专家共识[J].中华医学杂志,2024,104(15):1280-1309.
-
3刘志勤,刘鸣.高血压性脑出血规范化治疗进展[J].实用医院临床杂志,2008,5(2):22-25. 被引量:19
-
4叶红,宿英英.急性脑出血患者甘露醇输注前后脑血流的变化[J].中国脑血管病杂志,2008,5(11):499-503. 被引量:5
-
5梁元,韩占强,赵世光.神经导航辅助神经内镜清除脑室血肿[J].现代生物医学进展,2011,11(S2):5107-5108.
-
6Jinhui Zhao,Yuxiang Chen,Zhen Zhao,Qingchun Zhao,Dongmei Hao,ShanshanTang.Evaluation of cerebrovascular reactivity by ultrasonography in type 2 diabetic patients with hypertension[J].Neural Regeneration Research,2007,2(5):305-309. 被引量:2
-
7鲍瑞雪,马欣,贾建平,张通.卒中防治中的血压调控[J].国际脑血管病杂志,2007,15(9):669-674. 被引量:2
-
8陈娣,唐洲平,张苏明.自发性脑出血早期血肿增大[J].国际脑血管病杂志,2007,15(11):829-833. 被引量:16
-
9芦靖,于强.抗血栓药引发脑出血的治疗进展[J].临床荟萃,2008,23(6):447-449. 被引量:2
-
10刘利,林志国,沈红,张帆,浦松,杨富明,赵景波.影响立体定向血肿引流术治疗幕上高血压脑出血预后的多因素分析[J].中国临床神经外科杂志,2008,13(5):257-260. 被引量:1
同被引文献7
-
1李永杰,高旭光.重视抗栓治疗相关性脑出血[J].中国卒中杂志,2006,1(2):120-123. 被引量:8
-
2Steiner T, Rosand J, Diringer M. Intracerebral hemorrhage associated with oral anticoagulant therapy: current practices and unresolved questions[J]. Stroke, 2006, 37( 1 ) : 256 -262.
-
3Franke CL, de Jonge J, van Swieten JC, et al. Intracerebral hematomas during anticoagulant treatment [ J]. Stroke, 1990, 21 (5) : 726 - 730.
-
4Rosand J, Eckman MH, Knudsen KA, et al. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage[J]. Arch Intern Med, 2004, 164(8) : 880 -884.
-
5Sjijblom L, Hfirdemark HG, Lindgren A, et al. Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy : a Swedish muhicenter study [ J ]. Stroke, 2001, 32 ( 11 ) : 2567 - 2574.
-
6Towfighi A, Greenberg SM, Rosand J. Treatment and prevention of primary intracerebral hemorrhage [ J ]. Semin Neurol, 2005, 25 (4) : 445 - 452.
-
7张文高,杨学军,高松,纪延伟,王雷波,王增光,杨卫东,赵雅度(点评).抗血栓药物致脑出血的立体定向血肿抽吸治疗[J].中国现代神经疾病杂志,2009,9(1):55-59. 被引量:2
-
1何广华.盐酸胺碘酮治疗风湿性心脏病合并慢性心房颤动20例[J].实用医学杂志,1995,11(7):491-492. 被引量:3
-
2刘俊,徐航,葛卫红,王东进.基因组学个体化给药对心脏瓣膜术后华法林初始抗凝疗效的影响[J].中国药房,2014,25(4):330-332. 被引量:6
-
3本刊编辑部.温馨提示[J].家庭医药(就医选药),2016,0(3):61-61.
-
4谷晓昱,王宏.抗精神病药治疗精神分裂症引致糖尿病的相关因素分析[J].糖尿病新世界,2015,35(1):28-28. 被引量:2
-
5陈景生,张红飞,黄宇,李冬华.胺碘酮联合阿替洛尔治疗慢性心房颤动疗效观察[J].临床合理用药杂志,2011,4(13):22-23. 被引量:1
-
6何洪月,胡亚民,岳宁,李彬,苏晓燕,胡亚力.慢性心房颤动应用华法林抗凝治疗的现状分析[J].中国危重病急救医学,2005,17(7):402-402. 被引量:5
-
7芦靖,于强.抗血栓药引发脑出血的治疗进展[J].临床荟萃,2008,23(6):447-449. 被引量:2
-
8丁雅茹.地高辛、思诺思等有没有副作用?[J].家庭用药,2002(10):43-43.
-
9徐仁子.抗精神病药物引发精神分裂症患者糖尿病分析[J].中国药物滥用防治杂志,2008,14(6):359-360.
-
10张永利,赵明.抗凝药物治疗脑梗塞41例分析[J].职业与健康,1999,15(12):45-45.